Glycobiology companies study and engineer glycans, carbohydrates and glycoproteins involved in cellular communication, immunity and disease. Their technologies support drug discovery, biologics development, diagnostics and the characterisation of complex biological molecules.
This category includes companies working on:
Browse 10 UK glycobiology companies below.
Complex carbohydrate synthesis, catalogue products and CDMO services
Dextra Laboratories specialises in complex carbohydrate chemistry, supplying research products including oligosaccharides, monosaccharides, glycoconjugates and blood group antigens. It also offers contract development and manufacturing services for carbohydrate-based compounds, spanning discovery chemistry, process…
Carbohydrate binding molecules targeting the tumour glycome in cancer
Omideon is a Scottish preclinical biotechnology company applying multivalent carbohydrate binding molecule (mCBM) technology to oncology. Spun out from Pneumagen Limited by demerger in 2020, the company uses genetic engineering to develop mCBMs with high affinity for tumour-associated terminal glycans. Its lead…
Glycan analysis products and services for biopharmaceutical QC
Ludger is a glycobiology company specialising in the measurement and characterisation of protein glycosylation for biopharmaceutical development and quality control. The company manufactures glycan analysis kits, reagents, and reference standards for use in LC, MS, and CE workflows, and provides contract analytical…
Synthetic glucose-binding molecules for continuous glucose monitoring
Carbometrics Limited is a supramolecular chemistry biotech developing synthetic Glucose Binding Molecules (GBMs) for use in continuous glucose monitoring sensors and other diagnostic applications. The GBM platform uses a precisely engineered small-molecule scaffold to selectively bind glucose with high affinity and…
Blood glycomic biomarkers for chronic inflammatory disease detection and monitoring
Avenna is a biotechnology company developing blood-based glycomic biomarkers for chronic inflammatory diseases. Its tests analyse the sugar structures attached to blood proteins to measure chronic inflammation separately from short-term acute inflammation, supporting early detection, disease monitoring and…
Synthetic chemical receptor R&D for implantable glucose biosensors
Lifecare Chemistry Ltd is a UK R&D subsidiary of Norwegian medical sensor company Lifecare ASA, established to develop and own proprietary analyte-specific synthetic receptors for use in Lifecare's implantable continuous glucose monitoring technology. Working in collaboration with researchers at the University of…
Synthetic glycan-targeted small molecules for next-generation immunotherapy
Anomer Bio is a biotechnology company developing synthetic monosaccharides and small molecule drugs that target glycans, the sugars coating cell surfaces that influence immune responses and disease. Its platform combines multi-omics data and machine learning to model how cells process sugars, enabling the design of…
Cyanobacterial synthetic biology platform producing sustainable specialty chemicals
Deep Blue Biotech is a biotechnology company using genetically engineered cyanobacteria to produce high-value specialty chemicals as sustainable alternatives to fossil-derived ingredients. The platform uses carbon dioxide, light, and water as primary inputs, guided by AI-driven metabolic modelling, to manufacture…
Broad-spectrum intranasal antivirals targeting respiratory viral infections
Pneumagen is a Scottish clinical-stage biotechnology company developing broad-spectrum intranasal antiviral therapies. Pneumagen's platform generates multivalent carbohydrate binding molecules (mCBMs) that block viral entry by binding to sialic acid residues on host epithelial cells. In 2026, Pneumagen reorganized…
Glycan-based biological age and inflammaging diagnostics
GlycanAge is a biotechnology company that develops and sells diagnostic tests based on IgG glycan biomarkers. Its flagship product analyses glycans from a finger-prick blood sample to determine a customer's biological age, reflecting the degree of chronic inflammation driving immune ageing. Tests are available…